Showing results (141-150 of 170) with videos related to

Sort By:
Pageof 17
Urology|April 1, 1996
A dose-response study of the effect of flutamide on benign prostatic hyperplasia: results of a multicenter studyP Narayan, J Trachtenberg, H Lepor, et al.
Oncotarget|September 8, 2016
Epithelialization of mouse ovarian tumor cells originating in the fallopian tube stromaYuanyuan Hua, Pui-Wah Choi, Alexander J Trachtenberg, et al.
Neuroimage|August 14, 2010
Differential effects of the APOE genotype on brain function across the lifespanN Filippini, K P Ebmeier, B J MacIntosh, et al.
Urology|June 6, 2013
Should follow-up biopsies for men on active surveillance for prostate cancer be restricted to limited templates?L M Wong, G Trottier, A Toi, et al.
Cancer Genomics & Proteomics|July 27, 2010
TGF-beta1 interactome: metastasis and beyondM Perera, C S Tsang, R J Distel, et al.
Prostate Cancer and Prostatic Diseases|September 1, 2005
Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertiseM Speakman, J Batista, R Berges, et al.
Biological Chemistry|June 18, 2013
Current methods for the isolation of extracellular vesiclesFatemeh Momen-Heravi, Leonora Balaj, Sara Alian, et al.
Health Policy (Amsterdam, Netherlands)|March 3, 2020
Impact of payment model on the behaviour of specialist physicians: A systematic reviewAmity E Quinn, Aaron J Trachtenberg, Kerry A McBrien, et al.
British Journal of Cancer|November 1, 2007
Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancerR K Nam, L Sugar, W Yang, et al.
Prostate Cancer and Prostatic Diseases|June 15, 2005
Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinionF C Lowe, J Batista, R Berges, et al.
Pageof 17